Annual D&A
$322.00 K
+$118.00 K+57.84%
31 December 2023
Summary:
Quince Therapeutics annual depreciation & amortization is currently $322.00 thousand, with the most recent change of +$118.00 thousand (+57.84%) on 31 December 2023. During the last 3 years, it has fallen by -$10.00 thousand (-3.01%). QNCX annual D&A is now -6.40% below its all-time high of $344.00 thousand, reached on 31 December 2021.QNCX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$86.00 K
+$42.00 K+95.45%
30 September 2024
Summary:
Quince Therapeutics quarterly depreciation & amortization is currently $86.00 thousand, with the most recent change of +$42.00 thousand (+95.45%) on 30 September 2024. Over the past year, it has increased by +$86.00 thousand (+100.00%). QNCX quarterly D&A is now -71.71% below its all-time high of $304.00 thousand, reached on 31 December 2023.QNCX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$474.00 K
+$86.00 K+22.16%
30 September 2024
Summary:
Quince Therapeutics TTM depreciation & amortization is currently $474.00 thousand, with the most recent change of +$86.00 thousand (+22.16%) on 30 September 2024. Over the past year, it has increased by +$414.00 thousand (+690.00%). QNCX TTM D&A is now at all-time high.QNCX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.8% | +100.0% | +690.0% |
| 3 y3 years | -3.0% | -1.1% | +37.4% |
| 5 y5 years | +531.4% | +45.8% | +248.5% |
QNCX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.4% | +57.8% | -71.7% | at high | +690.0% | |
| 5 y | 5 years | -6.4% | +531.4% | -71.7% | at high | +690.0% | |
| alltime | all time | -6.4% | +615.6% | -71.7% | at high | +5825.0% |
Quince Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $86.00 K(+95.5%) | $474.00 K(+22.2%) |
| June 2024 | - | $44.00 K(+10.0%) | $388.00 K(+12.5%) |
| Mar 2024 | - | $40.00 K(-86.8%) | $345.00 K(+7.1%) |
| Dec 2023 | $322.00 K(+57.8%) | $304.00 K(>+9900.0%) | $322.00 K(+436.7%) |
| Sept 2023 | - | $0.00(-100.0%) | $60.00 K(-40.0%) |
| June 2023 | - | $1000.00(-94.1%) | $100.00 K(-45.4%) |
| Mar 2023 | - | $17.00 K(-59.5%) | $183.00 K(-10.3%) |
| Dec 2022 | $204.00 K(-40.7%) | $42.00 K(+5.0%) | $204.00 K(-17.1%) |
| Sept 2022 | - | $40.00 K(-52.4%) | $246.00 K(-16.0%) |
| June 2022 | - | $84.00 K(+121.1%) | $293.00 K(-1.0%) |
| Mar 2022 | - | $38.00 K(-54.8%) | $296.00 K(-14.0%) |
| Dec 2021 | $344.00 K | $84.00 K(-3.4%) | $344.00 K(-0.3%) |
| Sept 2021 | - | $87.00 K(0.0%) | $345.00 K(+0.9%) |
| June 2021 | - | $87.00 K(+1.2%) | $342.00 K(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $86.00 K(+1.2%) | $335.00 K(+0.9%) |
| Dec 2020 | $332.00 K(+76.6%) | $85.00 K(+1.2%) | $332.00 K(+2.8%) |
| Sept 2020 | - | $84.00 K(+5.0%) | $323.00 K(+8.4%) |
| June 2020 | - | $80.00 K(-3.6%) | $298.00 K(+18.3%) |
| Mar 2020 | - | $83.00 K(+9.2%) | $252.00 K(+34.0%) |
| Dec 2019 | $188.00 K(+268.6%) | $76.00 K(+28.8%) | $188.00 K(+38.2%) |
| Sept 2019 | - | $59.00 K(+73.5%) | $136.00 K(+56.3%) |
| June 2019 | - | $34.00 K(+78.9%) | $87.00 K(+40.3%) |
| Mar 2019 | - | $19.00 K(-20.8%) | $62.00 K(+21.6%) |
| Dec 2018 | $51.00 K(+13.3%) | $24.00 K(+140.0%) | $51.00 K(+88.9%) |
| Sept 2018 | - | $10.00 K(+11.1%) | $27.00 K(+58.8%) |
| June 2018 | - | $9000.00(+12.5%) | $17.00 K(+112.5%) |
| Mar 2018 | - | $8000.00 | $8000.00 |
| Dec 2017 | $45.00 K | - | - |
FAQ
- What is Quince Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Quince Therapeutics?
- What is Quince Therapeutics annual D&A year-on-year change?
- What is Quince Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Quince Therapeutics?
- What is Quince Therapeutics quarterly D&A year-on-year change?
- What is Quince Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Quince Therapeutics?
- What is Quince Therapeutics TTM D&A year-on-year change?
What is Quince Therapeutics annual depreciation & amortization?
The current annual D&A of QNCX is $322.00 K
What is the all time high annual D&A for Quince Therapeutics?
Quince Therapeutics all-time high annual depreciation & amortization is $344.00 K
What is Quince Therapeutics annual D&A year-on-year change?
Over the past year, QNCX annual depreciation & amortization has changed by +$118.00 K (+57.84%)
What is Quince Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of QNCX is $86.00 K
What is the all time high quarterly D&A for Quince Therapeutics?
Quince Therapeutics all-time high quarterly depreciation & amortization is $304.00 K
What is Quince Therapeutics quarterly D&A year-on-year change?
Over the past year, QNCX quarterly depreciation & amortization has changed by +$86.00 K (+100.00%)
What is Quince Therapeutics TTM depreciation & amortization?
The current TTM D&A of QNCX is $474.00 K
What is the all time high TTM D&A for Quince Therapeutics?
Quince Therapeutics all-time high TTM depreciation & amortization is $474.00 K
What is Quince Therapeutics TTM D&A year-on-year change?
Over the past year, QNCX TTM depreciation & amortization has changed by +$414.00 K (+690.00%)